IBDEI03B ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4139,1,3,0)
 ;;=3^Foreign Body, External Eye
 ;;^UTILITY(U,$J,358.3,4139,1,4,0)
 ;;=4^930.9
 ;;^UTILITY(U,$J,358.3,4139,2)
 ;;=Foreign Body, External Eye^275489
 ;;^UTILITY(U,$J,358.3,4140,0)
 ;;=372.51^^39^296^57
 ;;^UTILITY(U,$J,358.3,4140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4140,1,3,0)
 ;;=3^Pinguecula
 ;;^UTILITY(U,$J,358.3,4140,1,4,0)
 ;;=4^372.51
 ;;^UTILITY(U,$J,358.3,4140,2)
 ;;=Pinguecula^265525
 ;;^UTILITY(U,$J,358.3,4141,0)
 ;;=379.00^^39^296^23
 ;;^UTILITY(U,$J,358.3,4141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4141,1,3,0)
 ;;=3^Episcleritis
 ;;^UTILITY(U,$J,358.3,4141,1,4,0)
 ;;=4^379.00
 ;;^UTILITY(U,$J,358.3,4141,2)
 ;;=...^108564
 ;;^UTILITY(U,$J,358.3,4142,0)
 ;;=372.20^^39^296^9
 ;;^UTILITY(U,$J,358.3,4142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4142,1,3,0)
 ;;=3^Blepharoconjunctivitis
 ;;^UTILITY(U,$J,358.3,4142,1,4,0)
 ;;=4^372.20
 ;;^UTILITY(U,$J,358.3,4142,2)
 ;;=Blepharoconjunctivitis^15277
 ;;^UTILITY(U,$J,358.3,4143,0)
 ;;=372.40^^39^296^59
 ;;^UTILITY(U,$J,358.3,4143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4143,1,3,0)
 ;;=3^Pterygium
 ;;^UTILITY(U,$J,358.3,4143,1,4,0)
 ;;=4^372.40
 ;;^UTILITY(U,$J,358.3,4143,2)
 ;;=Pterygium^100819
 ;;^UTILITY(U,$J,358.3,4144,0)
 ;;=694.4^^39^296^56
 ;;^UTILITY(U,$J,358.3,4144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4144,1,3,0)
 ;;=3^Pemphigus
 ;;^UTILITY(U,$J,358.3,4144,1,4,0)
 ;;=4^694.4
 ;;^UTILITY(U,$J,358.3,4144,2)
 ;;=Pemphigus^91124
 ;;^UTILITY(U,$J,358.3,4145,0)
 ;;=224.3^^39^296^8
 ;;^UTILITY(U,$J,358.3,4145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4145,1,3,0)
 ;;=3^Benign Neoplasm Conjunctiva
 ;;^UTILITY(U,$J,358.3,4145,1,4,0)
 ;;=4^224.3
 ;;^UTILITY(U,$J,358.3,4145,2)
 ;;=Benign Neoplasm Conjunctiva^267673
 ;;^UTILITY(U,$J,358.3,4146,0)
 ;;=370.40^^39^296^41
 ;;^UTILITY(U,$J,358.3,4146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4146,1,3,0)
 ;;=3^Keratoconjunctivitis
 ;;^UTILITY(U,$J,358.3,4146,1,4,0)
 ;;=4^370.40
 ;;^UTILITY(U,$J,358.3,4146,2)
 ;;=^66777
 ;;^UTILITY(U,$J,358.3,4147,0)
 ;;=694.5^^39^296^55
 ;;^UTILITY(U,$J,358.3,4147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4147,1,3,0)
 ;;=3^Pemphigoid
 ;;^UTILITY(U,$J,358.3,4147,1,4,0)
 ;;=4^694.5
 ;;^UTILITY(U,$J,358.3,4147,2)
 ;;=Pemphigoid^91108
 ;;^UTILITY(U,$J,358.3,4148,0)
 ;;=364.10^^39^296^32
 ;;^UTILITY(U,$J,358.3,4148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4148,1,3,0)
 ;;=3^Iridocyclitis, Chronic
 ;;^UTILITY(U,$J,358.3,4148,1,4,0)
 ;;=4^364.10
 ;;^UTILITY(U,$J,358.3,4148,2)
 ;;=Iridocyclitis, Chronic^24398
 ;;^UTILITY(U,$J,358.3,4149,0)
 ;;=054.44^^39^296^33
 ;;^UTILITY(U,$J,358.3,4149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4149,1,3,0)
 ;;=3^Iridocyclitis, H Simplex
 ;;^UTILITY(U,$J,358.3,4149,1,4,0)
 ;;=4^054.44
 ;;^UTILITY(U,$J,358.3,4149,2)
 ;;=Iridocyclitis, H Simplex^266565
 ;;^UTILITY(U,$J,358.3,4150,0)
 ;;=053.22^^39^296^34
 ;;^UTILITY(U,$J,358.3,4150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4150,1,3,0)
 ;;=3^Iridocyclitis, H Zoster
 ;;^UTILITY(U,$J,358.3,4150,1,4,0)
 ;;=4^053.22
 ;;^UTILITY(U,$J,358.3,4150,2)
 ;;=Iridocyclitis, H Zoster^266554
 ;;^UTILITY(U,$J,358.3,4151,0)
 ;;=364.42^^39^296^63
 ;;^UTILITY(U,$J,358.3,4151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4151,1,3,0)
 ;;=3^Rubeosis Iridis
 ;;^UTILITY(U,$J,358.3,4151,1,4,0)
 ;;=4^364.42
 ;;^UTILITY(U,$J,358.3,4151,2)
 ;;=Rubeosis Iridis^268716
 ;;^UTILITY(U,$J,358.3,4152,0)
 ;;=364.77^^39^296^2
 ;;^UTILITY(U,$J,358.3,4152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4152,1,3,0)
 ;;=3^Angle Recession, Iris
 ;;^UTILITY(U,$J,358.3,4152,1,4,0)
 ;;=4^364.77
 ;;^UTILITY(U,$J,358.3,4152,2)
 ;;=Angle Recession, Iris^268743
 ;;^UTILITY(U,$J,358.3,4153,0)
 ;;=364.59^^39^296^35
 ;;^UTILITY(U,$J,358.3,4153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4153,1,3,0)
 ;;=3^Iris Atrophy
 ;;^UTILITY(U,$J,358.3,4153,1,4,0)
 ;;=4^364.59
 ;;^UTILITY(U,$J,358.3,4153,2)
 ;;=Iris Atrophy^268731
 ;;^UTILITY(U,$J,358.3,4154,0)
 ;;=224.0^^39^296^7
 ;;^UTILITY(U,$J,358.3,4154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4154,1,3,0)
 ;;=3^Benign Neopl of Iris
 ;;^UTILITY(U,$J,358.3,4154,1,4,0)
 ;;=4^224.0
 ;;^UTILITY(U,$J,358.3,4154,2)
 ;;=^267670
 ;;^UTILITY(U,$J,358.3,4155,0)
 ;;=364.72^^39^296^4
 ;;^UTILITY(U,$J,358.3,4155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4155,1,3,0)
 ;;=3^Anterior Synechiae
 ;;^UTILITY(U,$J,358.3,4155,1,4,0)
 ;;=4^364.72
 ;;^UTILITY(U,$J,358.3,4155,2)
 ;;=Anterior Synechiae^265517
 ;;^UTILITY(U,$J,358.3,4156,0)
 ;;=364.71^^39^296^58
 ;;^UTILITY(U,$J,358.3,4156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4156,1,3,0)
 ;;=3^Posterior Synechiae
 ;;^UTILITY(U,$J,358.3,4156,1,4,0)
 ;;=4^364.71
 ;;^UTILITY(U,$J,358.3,4156,2)
 ;;=Posterior Synechiae^265519
 ;;^UTILITY(U,$J,358.3,4157,0)
 ;;=364.00^^39^296^31
 ;;^UTILITY(U,$J,358.3,4157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4157,1,3,0)
 ;;=3^Iridocyclitis, Acute
 ;;^UTILITY(U,$J,358.3,4157,1,4,0)
 ;;=4^364.00
 ;;^UTILITY(U,$J,358.3,4157,2)
 ;;=Iridocyclitis, Acute^268703
 ;;^UTILITY(U,$J,358.3,4158,0)
 ;;=379.40^^39^296^60
 ;;^UTILITY(U,$J,358.3,4158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4158,1,3,0)
 ;;=3^Pupil, Abnormal function
 ;;^UTILITY(U,$J,358.3,4158,1,4,0)
 ;;=4^379.40
 ;;^UTILITY(U,$J,358.3,4158,2)
 ;;=Pupil, Abnormal function^101288
 ;;^UTILITY(U,$J,358.3,4159,0)
 ;;=190.0^^39^296^49
 ;;^UTILITY(U,$J,358.3,4159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4159,1,3,0)
 ;;=3^Malig Neopl of Iris
 ;;^UTILITY(U,$J,358.3,4159,1,4,0)
 ;;=4^190.0
 ;;^UTILITY(U,$J,358.3,4159,2)
 ;;=Malig Neopl of Iris^267271
 ;;^UTILITY(U,$J,358.3,4160,0)
 ;;=190.3^^39^296^48
 ;;^UTILITY(U,$J,358.3,4160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4160,1,3,0)
 ;;=3^Malig Neopl Conjunctiva
 ;;^UTILITY(U,$J,358.3,4160,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,4160,2)
 ;;=Malig Neopl Conjunctiva^267274
 ;;^UTILITY(U,$J,358.3,4161,0)
 ;;=364.41^^39^296^29
 ;;^UTILITY(U,$J,358.3,4161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4161,1,3,0)
 ;;=3^Hyphema
 ;;^UTILITY(U,$J,358.3,4161,1,4,0)
 ;;=4^364.41
 ;;^UTILITY(U,$J,358.3,4161,2)
 ;;=Hyphema^60498
 ;;^UTILITY(U,$J,358.3,4162,0)
 ;;=364.05^^39^296^30
 ;;^UTILITY(U,$J,358.3,4162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4162,1,3,0)
 ;;=3^Hypopyon
 ;;^UTILITY(U,$J,358.3,4162,1,4,0)
 ;;=4^364.05
 ;;^UTILITY(U,$J,358.3,4162,2)
 ;;=Hypopion^60720
 ;;^UTILITY(U,$J,358.3,4163,0)
 ;;=365.02^^39^296^3
 ;;^UTILITY(U,$J,358.3,4163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4163,1,3,0)
 ;;=3^Angle, Narrow
 ;;^UTILITY(U,$J,358.3,4163,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,4163,2)
 ;;=Angle, Narrow^268748
 ;;^UTILITY(U,$J,358.3,4164,0)
 ;;=372.63^^39^296^65
 ;;^UTILITY(U,$J,358.3,4164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4164,1,3,0)
 ;;=3^Symblepharon
 ;;^UTILITY(U,$J,358.3,4164,1,4,0)
 ;;=4^372.63
 ;;^UTILITY(U,$J,358.3,4164,2)
 ;;=Symblepharon^265885
 ;;^UTILITY(U,$J,358.3,4165,0)
 ;;=372.75^^39^296^20
 ;;^UTILITY(U,$J,358.3,4165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4165,1,3,0)
 ;;=3^Cysts, Conjunctival
 ;;^UTILITY(U,$J,358.3,4165,1,4,0)
 ;;=4^372.75
 ;;^UTILITY(U,$J,358.3,4165,2)
 ;;=Cysts, Conjunctival^269049
 ;;^UTILITY(U,$J,358.3,4166,0)
 ;;=364.81^^39^296^24
 ;;^UTILITY(U,$J,358.3,4166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4166,1,3,0)
 ;;=3^Floppy Iris Syndrome
 ;;^UTILITY(U,$J,358.3,4166,1,4,0)
 ;;=4^364.81
 ;;^UTILITY(U,$J,358.3,4166,2)
 ;;=^335254
 ;;^UTILITY(U,$J,358.3,4167,0)
 ;;=372.06^^39^296^17
 ;;^UTILITY(U,$J,358.3,4167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4167,1,3,0)
 ;;=3^Conjunctivitis,Chemical Acute
 ;;^UTILITY(U,$J,358.3,4167,1,4,0)
 ;;=4^372.06
 ;;^UTILITY(U,$J,358.3,4167,2)
 ;;=^338237
 ;;^UTILITY(U,$J,358.3,4168,0)
 ;;=379.31^^39^297^1
 ;;^UTILITY(U,$J,358.3,4168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4168,1,3,0)
 ;;=3^Aphakia
 ;;^UTILITY(U,$J,358.3,4168,1,4,0)
 ;;=4^379.31
 ;;^UTILITY(U,$J,358.3,4168,2)
 ;;=^9445
 ;;^UTILITY(U,$J,358.3,4169,0)
 ;;=366.15^^39^297^3
 ;;^UTILITY(U,$J,358.3,4169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4169,1,3,0)
 ;;=3^Cataract, Cortical
 ;;^UTILITY(U,$J,358.3,4169,1,4,0)
 ;;=4^366.15
 ;;^UTILITY(U,$J,358.3,4169,2)
 ;;=Cortical Senile Cataract^268797
 ;;^UTILITY(U,$J,358.3,4170,0)
 ;;=366.16^^39^297^5
 ;;^UTILITY(U,$J,358.3,4170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4170,1,3,0)
 ;;=3^Cataract, Nuclear Sclerosis
 ;;^UTILITY(U,$J,358.3,4170,1,4,0)
 ;;=4^366.16
 ;;^UTILITY(U,$J,358.3,4170,2)
 ;;=366.16^268800
 ;;^UTILITY(U,$J,358.3,4171,0)
 ;;=366.14^^39^297^6
 ;;^UTILITY(U,$J,358.3,4171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4171,1,3,0)
 ;;=3^Cataract, PSC/Post Subcapsular
 ;;^UTILITY(U,$J,358.3,4171,1,4,0)
 ;;=4^366.14
 ;;^UTILITY(U,$J,358.3,4171,2)
 ;;=Post Subcapsular Senile Cataract^268796
 ;;^UTILITY(U,$J,358.3,4172,0)
 ;;=V43.1^^39^297^16
 ;;^UTILITY(U,$J,358.3,4172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4172,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,4172,1,4,0)
 ;;=4^V43.1
 ;;^UTILITY(U,$J,358.3,4172,2)
 ;;=^69114^V45.61
 ;;^UTILITY(U,$J,358.3,4173,0)
 ;;=366.20^^39^297^11
 ;;^UTILITY(U,$J,358.3,4173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4173,1,3,0)
 ;;=3^Cataract, Traumatic
 ;;^UTILITY(U,$J,358.3,4173,1,4,0)
 ;;=4^366.20
 ;;^UTILITY(U,$J,358.3,4173,2)
 ;;=Traumatic Cataract, NOS^268802
 ;;^UTILITY(U,$J,358.3,4174,0)
 ;;=366.52^^39^297^7
 ;;^UTILITY(U,$J,358.3,4174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4174,1,3,0)
 ;;=3^Cataract, Post Capsular-not obscuring vision
 ;;^UTILITY(U,$J,358.3,4174,1,4,0)
 ;;=4^366.52
 ;;^UTILITY(U,$J,358.3,4174,2)
 ;;=Posterior Capsular Fibrosis Not Obscuring Vision^268822
 ;;^UTILITY(U,$J,358.3,4175,0)
 ;;=366.53^^39^297^8
 ;;^UTILITY(U,$J,358.3,4175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4175,1,3,0)
 ;;=3^Cataract, Post Capsular-obscuring vision
